NYSE: AHRAmerican Healthcare Reit Inc Stock
$48.32+0.08 (+0.17%)
Updated Nov 14, 2025
AHR Price
$48.32
Fair Value Price
N/A
Market Cap
$8.55B
52 Week Low
$26.40
52 Week High
$50.50
P/E
439.27x
P/B
3.19x
P/S
3.23x
PEG
3.84x
Dividend Yield
1.55%
Revenue
$2.20B
Earnings
$27.26M
Gross Margin
18.3%
Operating Margin
4.74%
Profit Margin
1.2%
Debt to Equity
0.77
Operating Cash Flow
$299M
Beta
0.55
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AHR's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Healthcare Facility REIT
Industry Rating
D
AHR
Ranked#1 of 17
Ranked#1 of 17
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $35.88 | C | |
| $12.05 | C | |
| $43.97 | C |
Be the first to know about important AHR news, forecast changes, insider trades & much more!
AHR News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AHR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AHR ($48.32) is trading above its intrinsic value of $5.30, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AHR is poor value based on its earnings relative to its share price (439.27x), compared to the US market average (44.99x)
P/E vs Market Valuation
AHR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more AHR due diligence checks available for Premium users.
Valuation
AHR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
439.27x
Industry
101.04x
Market
44.99x
AHR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AHR is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
AHR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.19x
Industry
2.63x
AHR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AHR price to earnings growth (PEG)
For valuing profitable companies with growth potential
AHR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
AHR's financial health
Profit margin
Revenue
$572.9M
Net Income
$55.9M
Profit Margin
9.8%
AHR's Earnings (EBIT) of $104.26M... subscribe to Premium to read more.
Interest Coverage Financials
AHR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.8B
Liabilities
$2.1B
Debt to equity
0.77
AHR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$107.2M
Investing
-$278.5M
Financing
$185.7M
AHR's operating cash flow ($298.79M)... subscribe to Premium to read more.
Debt Coverage Financials
AHR vs Healthcare Facility REIT Stocks
American Healthcare Reit Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.